About CJC-1295 (with DAC)
CJC-1295 with Drug Affinity Complex (DAC) is a modified GHRH analogue designed for extended activity in research settings. Supplied as a lyophilized powder for laboratory protocols investigating sustained GHRH-mediated signaling, pituitary pathway activity, and growth-factor regulation in controlled experimental models. The DAC modification supports longer-duration exposure designs relative to non-DAC analogues. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Detection of CJC-1295 in Equine Plasma by ELISA.
Recent research on CJC-1295 (with DAC): Detection of CJC-1295 in Equine Plasma by ELISA.
Read Full Study on PubMedRelated Research
Purchase CJC-1295 (with DAC) from Keystone Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.